Search results
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 2 days agoThe committee voted on the question, “For the 2024-2025 Formula of COVID-19 vaccines in the U.S.,...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 12 hours agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
New COVID variant KP.3 climbs to 25%, now largest in CDC estimates
CBS News· 7 hours agoThe new KP.3 variant has climbed to 1 in 4 new COVID-19 cases nationwide, the Centers for Disease...
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 23 minutes agovaccine and drugmaker GSK asked the FDA in February to expand approval beyond adults 60 and older,...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 6 hours agoThe submission is based on FDA guidance, which advised that COVID-19 vaccines should be updated to a...
COVID shots for JN.1 variant neutralize newer strains, vaccine makers say
WSAU Wausau· 2 days ago(Reuters) - COVID-19 vaccine makers said data from animals studies showed their 2024-25 shots...
FDA panel recommends new COVID-19 vaccine formula for fall
UPI· 1 day agovaccine makers to focus on the latest versions of the virus, and not the JN.1 variant. A U.S. Food...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 11 hours agoPfizer has also said it can jump in with a new pandemic influenza vaccine. Moderna stock has risen...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 5 days agoIn the briefing document, the FDA staff gave a brief history of coronavirus vaccines, noting that...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer | The Motley...
The Motley Fool· 4 days agoPfizer (PFE 0.61%) investors have been through a lot of ups and downs over the past few years....